CytoReason vs Immunai
CytoReason vs Immunai, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Immunai on 69/100.
Where each one leads
CytoReason
Leads on none of the measures we hold for both companies.
Immunai
- agent readiness: 32/100 against 21/100
- domain rating: 46/100 against 40/100
- headcount: 179 against 116
- funding raised: $295M against $128M
- LinkedIn following: 26,832 against 12,830
At a glance
| Measure | CytoReason | Immunai |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Immunology, Data, Analytics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2016 | 2019 |
| Headquarters | Tel Aviv, Israel | New York, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | CytoReason | Immunai |
|---|---|---|
| Employees | 116 | 179 |
| Headcount growthLast 12 months | +13.7% | +13.0% |
| Total funding | $128M | $295M |
| Latest round | Series B | Series B |
| Valuation | Not published | $1.0B |
| LinkedIn followers | 12,830 | 26,832 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Immunai |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 69/100 |
| Traction | 60/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 30/100 | 39/100 |
| Quality | 78/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Immunai |
|---|---|---|
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Segment | Google Tag Manager |
CytoReason vs Immunai: common questions
Which is better, CytoReason or Immunai?
On our 0-100 score Immunai rates higher (69/100 against 68/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do CytoReason and Immunai compare on the numbers?
Immunai leads on agent readiness (32/100 against 21/100), domain rating (46/100 against 40/100), headcount (179 against 116), funding raised ($295M against $128M), LinkedIn following (26,832 against 12,830).
Read the full CytoReason review and pricing or the Immunai review and pricing. You can also browse other CytoReason alternatives we track.